Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now later-stage tilt small index

Irritable Bowel Syndrome (IBS): later-stage trial registry

5 of 6 indexed Irritable Bowel Syndrome (IBS) trials are currently recruiting, with more weight in Phase 3-4.

Corpus placement: #2,866 of 28,707 conditions by registered trial count.

6 US clinical trials · 5 currently recruiting · #2,866 of 28,707 conditions by registered trial count

Irritable Bowel Syndrome (IBS): 6 US clinical trials tracked, 5 recruiting.

Irritable Bowel Syndrome (IBS) is the subject of 6 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most active sponsor is National University of Natural Medicine, running 1 of these trials.

Enrollment posture brief

Registry condition irritable-bowel-syndrome-ibs

OPEN 5 | RECR 83% | LATE 1 | EARLY 0 | RANK #2866 | SPON 1

Nearest open-share peer: Alcoholic Hepatitis (83% recruiting · 6 trials)

Irritable Bowel Syndrome (th…83%Acute Hypoxemic Respiratory 66.7%Abdominal Aortic Aneurysms50%Acupuncture50%Acute Lymphoblastic Leukemia50%
Open-enrollment share among volume-matched conditions near Irritable Bowel Syndrome (IBS)

Irritable Bowel Syndrome (IBS) lists 5 open slots (83% of 6 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Irritable Bowel Syndrome (IBS) on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Irritable Bowel Syndrome (IBS) is recruiting above its size-band peers.

    5 of 6 indexed trials (83.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Irritable Bowel Syndrome (IBS) research.

    National University of Natural Medicine accounts for 1 of 6 trials (16.7%). 6 distinct sponsors appear on at least one study for this condition label.

  3. Most Irritable Bowel Syndrome (IBS) trials plan to enrol fewer than 100 people.

    Median target enrolment is 90 among the 6 trials that report a genuine target (sentinel values excluded). 4 of those (66.7%) plan for fewer than 100 participants.

  4. Irritable Bowel Syndrome (IBS) splits between interventional and observational designs.

    3 interventional and 3 observational studies make up this index (50% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 31

Phase Distribution

PhaseTrial count
Phase 3 1

Named interventions

Most-linked intervention names on Irritable Bowel Syndrome (IBS) records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Alosetron Drug
1 trials
Wireless Patch System Diagnostic test
1 trials
Inulin Dietary supplement
1 trials
Naturopathic medicine Other
1 trials
Placebo Device Device
1 trials
Re-Timer glasses Device
1 trials
no intervention Other
1 trials

US sites by state

Facility locations filed on Irritable Bowel Syndrome (IBS) trials. A trial with sites in several states counts in each.

California 2 trials
South Carolina 1 trials
Pennsylvania 1 trials
Oregon 1 trials
Indiana 1 trials
Arizona 1 trials
Arkansas 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Irritable Bowel Syndrome (IBS) page

6 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Irritable Bowel Syndrome (IBS) condition card totals 6 registered trials; most-linked intervention Alosetron; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.